IGFBP4 overexpression can inhibit tumor proliferation and induce apoptosis by increasing the expression level of the proapoptotic protein BAX and decreasing that of the antiapoptotic protein BCL2 in A549 lung cancer cells (Wei et al., 2021). Here, BCL2 is linked to lung carcinoma.